Om Megashree Pharmaceuticals Limited has officially called its Special General Meeting to discuss several key agendas, including the acquisition of Royal Pharmaceuticals Private Limited. A board of directors meeting held on Asar 11 decided to convene the meeting on Asar 28 at 9:00 AM at the company’s factory premises in Chitwan.
Snow Rivers Limited IPO Listed on NEPSE
The primary proposal of this special meeting is the acquisition of Royal Pharmaceuticals Private Limited. Shareholders will discuss and endorse the board of directors’ report and approve all activities carried out so far regarding the acquisition process.
Key Agendas and Financial Valuations
During the meeting, the company will present the Due Diligence Audit report and the asset and liability valuation report for shareholder approval. The final share swap ratio agreed upon by both companies will also be put forward for endorsement.
Due to the acquisition process, the company will need to make necessary amendments to its authorized, issued, and paid-up capital. The meeting will seek approval to modify the company’s share structure, Memorandum of Association, and Articles of Association to reflect these changes.
Book Closure and Shareholder Eligibility
To determine eligibility for the meeting, Om Megashree Pharmaceuticals has announced that its book closure date will be on Asar 22. Only shareholders whose names are registered in the company’s records by Asar 21 will be allowed to participate and cast their votes during the Special General Meeting.